These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28491335)

  • 41. 25-hydroxyvitamin D deficiency in renal transplant recipients.
    Querings K; Girndt M; Geisel J; Georg T; Tilgen W; Reichrath J
    J Clin Endocrinol Metab; 2006 Feb; 91(2):526-9. PubMed ID: 16303843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitamin D and the risk of acute allograft rejection following human liver transplantation.
    Bitetto D; Fabris C; Falleti E; Fornasiere E; Fumolo E; Fontanini E; Cussigh A; Occhino G; Baccarani U; Pirisi M; Toniutto P
    Liver Int; 2010 Mar; 30(3):417-44. PubMed ID: 19849776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 1,25-dihydroxyvitamin-D3 but not the clinically applied marker 25-hydroxyvitamin-D3 predicts survival after stem cell transplantation.
    Peter K; Siska PJ; Roider T; Matos C; Bruns H; Renner K; Singer K; Weber D; Güllstorf M; Kröger N; Wolff D; Herr W; Ayuk F; Holler E; Stark K; Heid IM; Kreutz M
    Bone Marrow Transplant; 2021 Feb; 56(2):419-433. PubMed ID: 32855442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High prevalence of vitamin D insufficiency in southern Chinese renal transplant recipients.
    Ma MK; Mok MM; Yung S; Tang CS; Chan TM
    Ren Fail; 2012; 34(8):980-4. PubMed ID: 22880802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal.
    Saull HE; Enderby CY; Gonwa TA; Wadei HM
    Clin Transplant; 2015 Jul; 29(7):573-80. PubMed ID: 25711849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Obesity in pediatric kidney transplant recipients and the risks of acute rejection, graft loss and death.
    Ladhani M; Lade S; Alexander SI; Baur LA; Clayton PA; McDonald S; Craig JC; Wong G
    Pediatr Nephrol; 2017 Aug; 32(8):1443-1450. PubMed ID: 28361229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children.
    Yao G; Albon E; Adi Y; Milford D; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2006 Dec; 10(49):iii-iv, ix-xi, 1-157. PubMed ID: 17134597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin 2 receptor antagonists for kidney transplant recipients.
    Webster AC; Ruster LP; McGee R; Matheson SL; Higgins GY; Willis NS; Chapman JR; Craig JC
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD003897. PubMed ID: 20091551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 25-hydroxyvitamin D deficiency and opportunistic viral infections after kidney transplant.
    Rech MA; Fleming JN; Moore CL
    Exp Clin Transplant; 2014 Apr; 12(2):95-100. PubMed ID: 24702139
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
    Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C
    Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum neopterin as an indicator of increased risk of renal allograft rejection.
    Carey BS; Jain R; Adams CL; Wong KY; Shaw S; Tse WY; Kaminski ER
    Transpl Immunol; 2013 Mar; 28(2-3):81-5. PubMed ID: 23481351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of mycophenolate mofetil on recurrent rejection in kidney transplant patients.
    Vasquez EM; Sifontis NM; Pollak R; Benedetti E
    Clin Transplant; 2001 Aug; 15(4):253-7. PubMed ID: 11683819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk variables associated with the outcome of kidney recipients >70 years of age in the new millennium.
    Heldal K; Hartmann A; Leivestad T; Foss A; Midtvedt K
    Nephrol Dial Transplant; 2011 Aug; 26(8):2706-11. PubMed ID: 21285131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HLA-DQ Mismatches and Rejection in Kidney Transplant Recipients.
    Lim WH; Chapman JR; Coates PT; Lewis JR; Russ GR; Watson N; Holdsworth R; Wong G
    Clin J Am Soc Nephrol; 2016 May; 11(5):875-883. PubMed ID: 27034399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.
    Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O
    Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
    J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial.
    Courbebaisse M; Alberti C; Colas S; Prié D; Souberbielle JC; Treluyer JM; Thervet E
    Trials; 2014 Nov; 15():430. PubMed ID: 25376735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients.
    Montero N; Webster AC; Royuela A; Zamora J; Crespo Barrio M; Pascual J
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD007669. PubMed ID: 25220222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low vitamin D levels are associated with increased rejection and infections after lung transplantation.
    Lowery EM; Bemiss B; Cascino T; Durazo-Arvizu RA; Forsythe SM; Alex C; Laghi F; Love RB; Camacho P
    J Heart Lung Transplant; 2012 Jul; 31(7):700-7. PubMed ID: 22386448
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Belatacept for kidney transplant recipients.
    Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.